Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01673893 · ClinicalTrials.gov registry record
ClearWay Rx Readmission Registry
A clinical trial of Acute Myocardial Infarction, sponsored by Cardiovascular Institute of the South Clinical Research Corporation.
- Completed
- Registry status
- 59
- Enrollment target
- 1
- Study location
NCT01673893 is a study of Acute Myocardial Infarction that has completed, run by Cardiovascular Institute of the South Clinical Research Corporation. The registered enrollment target is 59 participants, below the 1,879-participant average among 19 other Acute Myocardial Infarction trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01673893, a study of Acute Myocardial Infarction, has completed, sponsored by Cardiovascular Institute of the South Clinical Research Corporation.
- COMPLETED
- Registry status
- 59 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this registry is to determine if delivery of weight adjusted, in a large dose with either Abcixmab or Eptifibitide through the ClearWay™ RX, in patients admitted for primary coronary intervention lowers readmission rate. This is done in comparison to the historical control of the Medicare/Medicaid readmission database. The registry will record the use of the product during the index procedure, and determine whether or not the patient was readmitted within 30 days, related to the index procedure.
Conditions Studied
Interventions
- DEVICE ClearWay™ Rx catheter
Study Locations (1)
Louisiana
- Cardiovascular Institute of the South Clinical Research Corporation - Lafayette
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2011-09 |
| Est. Completion | 2014-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01673893
The ClinicalTrials.gov registry entry for NCT01673893 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 59 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,879-participant average among 19 other Acute Myocardial Infarction trials with a reported enrollment target (97% lower). The listed sponsor is Cardiovascular Institute of the South Clinical Research Corporation, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Acute Myocardial Infarction appearing as the primary indexed condition, and to 1 intervention - of which ClearWay™ Rx catheter is the first listed.
NCT01673893 reports 1 study location spanning 1 distinct geographic area - top geographies include Louisiana.
Frequently Asked Questions
What is clinical trial NCT01673893 about?
NCT01673893 is a clinical study titled "ClearWay Rx Readmission Registry". The purpose of this registry is to determine if delivery of weight adjusted, in a large dose with either Abcixmab or Eptifibitide through the ClearWay™ RX, in patients admitted for primary coronary intervention lowers readmission rate. This is done in comparison to the historical control of the Medi...
What is the current status of trial NCT01673893?
This trial is currently completed. The enrollment target is 59 participants. The study started on 2011-09. Estimated completion is 2014-04.
What conditions does trial NCT01673893 study?
This clinical trial studies the following conditions: Acute Myocardial Infarction.
What interventions are being tested in trial NCT01673893?
The interventions under investigation include: ClearWay™ Rx catheter (DEVICE).
Who is sponsoring clinical trial NCT01673893?
This trial is sponsored by Cardiovascular Institute of the South Clinical Research Corporation, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01673893 being conducted?
This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Myocardial Infarction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Delivery SSO2 Therapy for 60 Min in Anterior MI Patients With PCI ≤ 6 Hours of Symptoms Onset Compared to Standard.
RECRUITING · NA
-
Multi-center Collaborative to Enhance Quality and Outcomes in the Management of Cardiogenic Shock
RECRUITING
-
Abbott Vascular Medical Device Registry
RECRUITING
-
Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease
RECRUITING · NA
-
Arrhythmia Detection After MI
RECRUITING · NA
-
COmparisoN of High-sensitivity Cardiac TRoponin I and T ASsays Trial
ACTIVE NOT RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.